Zonegran is indicated as monotherapy in the treatment of partial seizures, with or without secondary generalisation, in adults with newly diagnosed epilepsy (see Pharmacology: Pharmacodynamics under Actions); adjunctive therapy in the treatment of partial seizures, with or without secondary generalisation, in adults, adolescents and children aged 6 years and above.